Doliver Advisors’s Novo Nordisk NVO Stock Holding History

Doliver Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$502K	Sell	13,236 -3,505	-21%	-$162K	0.11%	119
2026 Q2	$803K	Buy	16,741 +3,415	+26%	+$147K	0.18%	94
2026 Q1	$490K	Buy	13,326 +1,342	+11%	+$63.6K	0.11%	116
2025 Q4	$610K	Sell	11,984 -977	-8%	-$50K	0.15%	107
2025 Q3	$719K	Buy	12,961 +3,049	+31%	+$178K	0.19%	94
2025 Q2	$684K	Sell	9,912 -5,778	-37%	-$393K	0.19%	90
2025 Q1	$1.09M	Sell	15,690 -535	-3%	-$44.2K	0.31%	57
2024 Q4	$1.4M	Buy	16,225 +5,721	+54%	+$619K	0.39%	43
2024 Q3	$1.25M	Sell	10,504 -188	-2%	-$25.1K	0.34%	52
2024 Q2	$1.53M	Sell	10,692 -81	-0.8%	-$10.7K	0.43%	39
2024 Q1	$1.38M	Buy	+10,773	New	+$1.28M	0.39%	46

Other funds holding NVO

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.71B AUM 69.59% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Doliver Advisors's NVO Position: Q3 2026 in Review

Doliver Advisors reduced its Novo Nordisk (NVO) stake by 21% in Q3 2026, selling an estimated $162K and leaving 13,236 shares worth $502K. The position accounts for 0.11% of the portfolio, ranked #119.

Doliver Advisors first reported a position in NVO in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.53M in Q2 2024. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Doliver Advisors held 13,236 shares of Novo Nordisk worth $502K as of Q3 2026.
Doliver Advisors sold 3,505 Novo Nordisk shares in Q3 2026, an estimated $162K.
Novo Nordisk made up 0.11% of Doliver Advisors's portfolio in Q3 2026, its #119 holding.
Doliver Advisors first reported a position in Novo Nordisk in Q1 2024 and has held it in 11 quarters since.
Doliver Advisors's Novo Nordisk position peaked at $1.53M in Q2 2024.
1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Doliver Advisors's 13F filing for Q3 2026, filed 1 Oct 2026.